Clinical trials sponsored by Guangzhou Institute of Respiratory Disease
3
Recruiting trials
8
Conditions studied
Phase breakdown
Phase 2 1Not applicable 2
Conditions studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Asthma | 1 |
| Asthma in Children | 1 |
| COPD | 1 |
| Extensive-Stage Small Cell Lung Cancer | 1 |
| Genetic Disease | 1 |
| Inflammation | 1 |
| Lung Cancer Squamous Cell | 1 |
Recruiting trials led by Guangzhou Institute of Respiratory Disease
- Association Between Genetic Polymorphisms and Type 2 Asthma in Children
- Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC
- To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)
Common questions
How many trials is Guangzhou Institute of Respiratory Disease recruiting for?
Guangzhou Institute of Respiratory Disease is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.